The dexamethasone suppression test and the diagnosis of depression in adults with severe and profound developmental disabilities.
The DST is too unreliable for depression screening in adults with severe or profound ID—use caregiver-based scales like ADAMS or HADS.
01Research in Context
What this study did
Researchers gave the dexamethasone suppression test (DST) to adults with severe or profound intellectual disability. They wanted to see if the blood test could spot depression in this group. The study was a small case series run in 1995.
What they found
The test failed. It found depression in only 22 % of the adults who were actually depressed. Doctors could be less than 35 % sure any result was right. The DST was wrong more often than it was right.
How this fits with other research
Later work shows better tools exist. McLennan et al. (2008) adapted the Hospital Anxiety and Depression Scale for adults with ID and got good reliability. Madden et al. (2003) built the ADAMS scale just for people with ID and also found strong psychometrics. These studies extend the 1995 paper by giving you workable screens after the DST flopped.
Vargas-Vargas et al. (2015) and Putnam et al. (2003) ran similar small psychometric studies. Both found their tools had limits, backing up the idea that mainstream tests often miss the mark in severe ID. The field has moved from blood tests to caregiver interviews and adapted questionnaires.
Why it matters
If you assess mood in adults with severe or profound ID, skip the DST. Use the ADAMS or the adapted HADS instead. They give you scores you can trust and save you from false negatives. Start with a caregiver interview and add one of these validated scales when you need a written baseline.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Replace any DST orders with the ADAMS or adapted HADS and interview the caregiver.
02At a glance
03Original abstract
The dexamethasone suppression test (DST) was administered to 40 adults with severe and profound mental retardation. All participants were free from known conditions which may have given misleading results from cortisol assay. Of nine participants who showed symptoms possibly indicating depression the DST results concurred in two cases (i.e. there were two true-positives). However there were four or five (depending on criteria adopted) false-positive DST results. There did not appear to be a consistent behavioural profile for positive DST responders. With sensitivity to possible depression estimated at 22%, and a diagnostic confidence of < 35%, these data do not support recommendations that the DST is useful for assisting in diagnosis of depression in this population.
Journal of intellectual disability research : JIDR, 1995 · doi:10.1111/j.1365-2788.1995.tb00519.x